Good news. OWCP has entered into a collaborative study with Sourasky Medical Center in Tel Aviv. The study will test the tolerability and effectiveness (my word) of the sublingual tablet for treating chronic lower back pain. I presume this is the study they planned to start sometime during the second quarter 2019.........seems like we are slightly ahead of schedule.
(0)
(0)
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links